Score Breakdown
Offering Ability
60
Cash Runway
40
Float Risk
9
Warrant Exposure
40
Convertible Debt
60
Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
model est. 20%
🔁 Convertible Conversion
model 40%
• Significant convertible debt: 28% potential dilution
• Elevated convertible risk (60/100)
Market Data
Market Cap$23.2K
Shares Outstanding232.37M
Float208.41M
CashN/A
Debt$3.20M
Short InterestN/A
Institutional Holdings
2 institutional holders · 25.5K shares
#1
BARCLAYS PLC
24.9K shares
#2
FNY Investment Advisers, LLC
600 shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest65.4K
Days to Cover1.0
% of Float0.0%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2024-11-22
xbrl
XBRL WARRANT
2023-12-31
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual OCEA Dilution Snapshot
Ocean Biomedical, Inc. (OCEA) has a DilutionScore of 43/100, rated Medium dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for OCEA: xbrl on 2024-11-22; xbrl on 2023-12-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — MEDIUM Risk
Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles: